2 news items
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
NMRA
14 May 24
in this press release, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
NMRA
15 Apr 24
of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties that could cause the actual results
- Prev
- 1
- Next